Position in INCY
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,430,861
+$559,618 QoQ
Shares Held
36,452
+25.4% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AGF MANAGEMENT LTD holds $202,046,769 across 8 Biotechnology names. INCY ranks #5 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
125,069 | $91,331,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
201,403 | $89,934,495 | |
| 3 | INSM |
INSMED Inc
|
57,458 | $9,395,532 | |
| 4 | RPRX |
Royalty Pharma plc
|
81,471 | $3,908,163 | |
| 5 | INCY |
Incyte Corp
This page
|
36,452 | $3,430,861 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
51,831 | $3,349,836 | |
| 7 | ZYME |
Zymeworks Inc.
|
15,000 | $375,600 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
415 | $320,645 |
All Filings in INCY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,430,861 | 36,452 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,871,243 | 29,070 | Shares | Sole | 2026-02-17 | |
| 2024-03-31 | $232,209 | 4,076 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $2,686,247 | 46,499 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,429,289 | 55,089 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,216,520 | 44,507 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $3,521,710 | 43,846 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||